To determine if ERK1/2 mediated TFF3 cellular functions in CMS4 CRC cells, a MEK inhibitor (CI-1040) was used that specifically inhibited the phosphorylation of ERK1/2 (Figure 6C). The gene discussed is TFF3; the disease is colorectal carcinoma.